Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ALG13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TRPC5OS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRPC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAPN6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LHFPL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AMOT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HTR2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL13RA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on